Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchAmubarvimab/romlusevimabAmubarv../r.. (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Amubarvimab/romlusevimab for COVID-19: real-time meta analysis of 4 studies

Covid Analysis
Mar 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Significantly lower risk is seen for viral clearance. 2 studies from 2 independent teams (both from the same country) show significant benefit.
Meta analysis using the most serious outcome reported shows 25% [-70‑66%] lower risk, without reaching statistical significance. Results are better for Randomized Controlled Trials and higher quality studies. Early treatment shows efficacy while late treatment does not, consistent with expectations for an antiviral treatment.
Currently there is limited data, with only 31 control events for the most serious outcome in trials to date.
Efficacy is variant dependent. mAb use may create new variants that spread globally1,2, and may be associated with prolonged viral loads, clinical deterioration, and immune escape2-5.
No treatment is 100% effective. Protocols combine safe and effective options with individual risk/benefit analysis and monitoring. Other treatments are more effective. All data and sources to reproduce this analysis are in the appendix.
Covid Analysis et al., Mar 2025, preprint, 1 author.
This PaperAmubarv../r..All
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit